17.03.2025 | Article
Product Launch Tracker: HCPs excited about the new wave of oncology therapies for patients
CREATION.co identified 8,501 HCP mentions on social media of launches and approvals.
By Jessica Fernandes
22.11.2024 | Article
Product Launch Tracker: HCPs reignited conversation around the FDA’s clearance of Traumagel
Discover which drug approvals HCPs are talking about online.
By Jessica Fernandes
18.10.2024 | Article
Product Launch Tracker: HCPs celebrated the FDA’s approval of FluMist
Discover which drug approvals HCPs are talking about online.
By Jessica Fernandes
11.09.2024 | Article
Product Launch Tracker: HCPs welcomed the FDA’s approval of updated COVID-19 vaccines
Discover which drug approvals HCPs are talking about online.
By Jessica Fernandes
06.08.2024 | Article
Product Launch Tracker: Excitement among HCPs as FDA approves Kisunla for early symptomatic Alzheimer’s disease
Discover which drug approvals HCPs are talking about online
By Abel Thomas
12.07.2024 | Article
Product Launch Tracker: Delight for clinical investigator as first telomerase inhibitor approved
Discover which drug approvals HCPs are talking about online
By Jamie Doggett
06.06.2024 | Article
Product Launch Tracker: oncologists pleased with new options for lymphomas, lung cancer and urothelial cancer
Discover which drug approvals HCPs are talking about online
By Jamie Doggett
09.05.2024 | Article
Product Launch Tracker: eHCPs are delighted with the approval of Enhertu, for patients with HER2-positive solid tumours.
Discover which drug approvals HCPs are talking about online
By Alexandra Maria Chatziioannidou
02.04.2024 | Article
Product Launch Tracker: eHCPs celebrated the first approved treatment for patients with NASH
Discover which drug approvals HCPs are talking about online
By Alexandra Maria Chatziioannidou
12.03.2024 | Article
Product Launch Tracker: eHCPs are enthusiastic about the first cellular therapy for advanced melanoma.
Discover which new drug approvals HCPs are talking about online
By Alexandra Maria Chatziioannidou
01.02.2024 | Article
Product Launch Tracker: eHCPs celebrate approval in cervical cancer
Discover which new drug approvals HCPs are talking about online
By Alexandra Maria Chatziioannidou
05.01.2024 | Article
Product Launch Tracker: Hundreds of eHCPs are enthusiastic about the first Sickle Cell Disease gene therapies.
Discover which new drug approvals HCPs are talking about
By Alexandra Maria Chatziioannidou
13.12.2023 | Article
Product Launch Tracker: eHCPs optimistic about Wegovy competitor’s obesity approval
Discover which new drug approvals HCPs are talking about
By Alexandra Maria Chatziioannidou
02.11.2023 | Article
Product Launch Tracker: eHCPs had positive reaction to the approval of the Novavax COVID-19 vaccine.
Discover what new drug approvals HCPs are talking about
By Alexandra Maria Chatziioannidou
06.10.2023 | Article
Product Launch Tracker: eHCPs had mixed opinions on the updated mRNA COVID-19 booster vaccines.
Discover what healthcare professionals (HCPs) think about pharmaceutical companies
By Alexandra Maria Chatziioannidou
01.09.2023 | Article
Product Launch Tracker: eHCPs thrilled about approval of first oral treatment for postpartum depression
Discover which new drug approvals HCPs are talking about
By Alexandra Maria Chatziioannidou
02.08.2023 | Article
Product Launch Tracker: eHCPs applauded the approval of Opill, the first non-prescription contraceptive.
Discover which new drug approvals HCPs are talking about
By Alexandra Maria Chatziioannidou
08.07.2023 | Article
Product Launch Tracker: eHCPs are delighted with the approval of Talzenna for prostate cancer.
Discover which new drug approvals HCPs are talking about
By Alexandra Maria Chatziioannidou
01.05.2023 | Article
Product Launch Tracker: HCPs are captivated by the approval of Vowst, a faecal microbiota product.
Discover which new drug approvals HCPs are talking about
By Alexandra Maria Chatziioannidou
01.04.2023 | Article
Product Launch Tracker: HCPs are enthusiastic about the approval of two nasal sprays and an antifungal treatment.
Discover which new drug approvals HCPs are talking about
By Alexandra Maria Chatziioannidou
05.02.2023 | Article
Product Launch Tracker: HCPs start the year discussing approvals for Alzheimer’s and several cancer treatments.
HCP's in the month of Jan discussed online their thoughts on a new treatment for Alzheimer’s
By Paul Cranston
15.01.2023 | Article
Product Launch Tracker: HCPs discuss pre-Christmas approvals in precision medicine, oncology and infectious disease
At the start of the month, HCPs were interested in the first faecal microbiota product
By Paul Cranston
16.12.2022 | Article
Product Launch Tracker: HCPs discuss first drug to delay type 1 diabetes and the approval of world’s most expensive treatment
In Nov. 2022 HCPs discussed treatments for multiple myeloma, gene therapy and diabetes.
By Paul Cranston
14.11.2022 | Article
Product Launch Tracker: HCPs share optimism for approvals in heart failure, obesity and multiple myeloma
HCP's shared the news on product approvals for issues like obesity, multiple myeloma, etc.
By Paul Cranston and Tomi Shobande
05.07.2022 | Article
Product Launch Tracker: HCPs discuss approvals including for the prevention of smallpox and monkeypox.
HCPs also held around the approval of treatments for monkeypox
By Paul Cranston and Tomi Shobande
02.07.2022 | Article
Product Launch Tracker: HCPs celebrate 5th agnostic approval in Cancer alongside other approvals
with notable excitement being found for the FDA’s approval of Novartis’ 5th agnostic...
By Paul Cranston and Tomi Shobande
06.06.2022 | Article
Product Launch Tracker: HCPs excited by approvals for Eli Lilly, Novartis, Sanofi and Regeneron
Over the last month, HCPs discussed product approvals for the treatment of a variety...
By Paul Cranston and Tomi Shobande
19.05.2022 | Article
Product Launch Tracker: HCPs excited for BMS’ newly approved ‘Camzyos’
Discover which new drug approvals HCPs are talking about
By Paul Cranston and Tomi Shobande
12.04.2022 | Article
Product Launch Tracker: HCPs discuss approvals for several cancer treatments and a fourth dose of COVID-19 vaccines
HCPs discuss approvals for several cancer treatments and a fourth dose of COVID-19 vaccines
By Paul Cranston and Tomi Shobande
11.03.2022 | Article
Product Launch Tracker: Approvals for Boehringer Ingelheim, Eli Lilly, and Novo Nordisk focus of HCP conversations
HCPs discuss approvals for Boehringer Ingelheim, Eli Lilly, and Novo Nordisk
By Paul Cranston and Tomi Shobande
09.02.2022 | Article
Product Launch Tracker: HCPs celebrate new treatments for metastatic melanoma and non-small cell lung cancer
HCPs also shared the news of approvals of treatments for NSCLC
By Paul Cranston and Tomi Shobande
10.01.2022 | Article
Product Launch Tracker: Pre-Christmas approvals drive HCPs conversations
Discover which new drug approvals dominated HCPs conversations pre-Christmas...
By Paul Cranston and Tomi Shobande
01.12.2021 | Article
Product Launch Tracker: HCPs welcome approvals for MSD’s Keytruda and Takeda’s Livtencity
Discover which new drug approvals HCPs are talking about
By Paul Cranston and Tomi Shobande
01.10.2021 | Article
Product Launch Tracker: FDA’s Pfizer vaccine approval continues to drive HCPs conversations
Discover which new drug approvals and launches HCPs are talking about
By Francesca Gan and Chawanzi Chintu
01.08.2021 | Article
Product Launch Tracker: HCPs celebrate Merck & Co and Bayer approvals, while discussing Moderna’s extension at length
Discover which new drug approvals HCPs are talking about
By Aaron Pitkin
